Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell CarcinomaShogo Shigeta, Christopher J. Kemp|Molecular Cancer Therapeutics|2021Cited by 30
MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 ExpressionShogo Shigeta, Nobuo Yaegashi|The Tohoku Journal of Experimental Medicine|2022Cited by 3